Trial Profile
The evaluation for usefulness of dienogest to prevent decline of ovarian reserve by cystectomy for endometriomas
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2020
Price :
$35
*
At a glance
- Drugs Dienogest (Primary) ; Buserelin
- Indications Endometriosis
- Focus Pharmacodynamics
- 12 Feb 2020 Status changed from active, no longer recruiting to discontinued.
- 09 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 06 Oct 2015 New trial record